Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.240
-0.020 (-1.59%)
Jun 4, 2025, 1:23 PM - Market open
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $134.16 million as of June 4, 2025. Its market cap has increased by 202.59% in one year.
Market Cap
134.16M
Enterprise Value
144.45M
1-Year Change
202.59%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $134.16M, a decrease of -73.91%. That is a compound annual growth rate of -30.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 136.33M | 200.32% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |